Bambino Gesù Hospital and Research Institute — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Bambino Gesù Hospital and Research Institute appears in 14 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials14

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

14 shown

Reprogramming Energy Homeostasis in Overweight Individuals Via Exercise, Cognitive, and Social TrainingNCT06931730 · lead sponsor · 2024-02-08

Home Monitoring in Pediatric Heart FailureNCT05017077 · lead sponsor · 2021-09-01

Early Administration of Ivabradine in Children With Heart FailureNCT04405804 · lead sponsor · 2020-06-20

Omalizumab in Severe Asthmatics With Food AllergyNCT06316414 · lead sponsor · 2018-01-01

Sleeve Gastrectomy in Adolescents With Complicated Morbid Obesity and NAFLDNCT02564679 · lead sponsor · 2014-07-01

Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.NCT02070211 · lead sponsor · 2014-06-01

DHA and Vitamin D in Children With Biopsy-proven NAFLDNCT02098317 · lead sponsor · 2014-01-01

Obalon in Children With Severe ObesityNCT02137330 · lead sponsor · 2014-01-01

Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisNCT01934777 · lead sponsor · 2013-10-01

Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°NCT01650025 · lead sponsor · 2012-08-01

Fenoldopam in Pediatric Cardiac SurgeryNCT00982527 · lead sponsor · 2009-09-01

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)NCT00885313 · lead sponsor · 2009-03-01

Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and YouthNCT04301154 · collaborator · 2022-02-18

Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics BaseNCT02951546 · collaborator · 2016-10-01

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Bambino Gesù Hospital and Research Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor12

collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.